ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

In Brief: MSK Opens Laurence Rockefeller Pavilion; Bush Event raised 410 Million for Anderson

July 9, 1999

Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds

April 27, 2007

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

House Passes Bill Authorizing NIH Funds; Veto Likely

August 2, 1991

NCI Will Get $1.3 Billion, But Only If Congress Fends Off GRH Cuts, Reprogramming For Drug War

October 3, 1986